If I Could Only Buy 2 Dividend Stocks Right Now (May 2025)

Home » If I Could Only Buy 2 Dividend Stocks Right Now (May 2025 Edition)

If I Could Only Buy 2 Dividend Stocks Right Now (May 2025 Edition)

In this article, I introduce two strategic additions to The Dividend Income Accelerator Portfolio: Novo Nordisk (NVO) and Novartis (NVS). These globally leading healthcare companies strengthen the portfolio’s sector and geographical diversification, reduce volatility, and enhance dividend growth potential—key elements of our risk-reward optimized investment approach.

Novo Nordisk, based in Denmark, has a P/E [FWD] Ratio of 15.99, significantly below its 5-year average of 31.22, and currently offers a Dividend Yield [FWD] of 3.55%. With a 5-Year Dividend Growth Rate [CAGR] of 21.92%, it contributes meaningfully to long-term income compounding.

Novartis, headquartered in Switzerland, has a P/E [FWD] Ratio of 14.64, well below its historical average, and offers a Dividend Yield [FWD] of 3.80%. Its strong profitability and a 5-Year Dividend Growth Rate [CAGR] of 6.44% further reinforce the portfolio’s income growth foundation.

Following these additions, our Health Care exposure increases from 7.05% to 11.28%, while international exposure grows from 13.08% to 16.58%. The portfolio now holds a Weighted Average Yield on Cost [TTM] of 4.41% and a 5-Year Dividend Growth Rate [CAGR] of 7.72%.

Read the full analysis on Seeking Alpha.

Deutsche Post: High Free Cash Flow, Strong Dividend, and Undervalued

Deutsche Post and its subsidiary DHL are global leaders in logistics and mail services, combining traditional postal strengths with … Read More

Meta Platforms Stock Analysis: AI Growth, Financial Strength & FM Global Risk-Reward Score of 74/100

Meta Platforms is a global technology leader, known for its social media dominance, cutting-edge artificial intelligence innovations, and early … Read More

Is Altria a Good Dividend Stock for Long-Term Income? Yield, Risk, and Competitive Edge

Altria (NYSE: MO) is widely known among income-oriented investors for its consistently high dividend yield and iconic brand portfolio. … Read More

Is Apple Stock a Buy Now? A Deep Dive Into Dividends, Growth, and Valuation

Apple stands as one of the most iconic and valuable companies in the world, known for its innovative products, … Read More

Alphabet Stock: Strong Buy With 82/100 Risk-Reward Score, AI Leadership, and Dividend Growth Potential

Alphabet stands as one of the most innovative companies in the world, operating at the intersection of technology, data, … Read More

SCHD: A Strong Buy Based on the FM Global Invest Risk-Reward Rating

Based on the FM Global Invest Risk-Reward Rating for ETFs, the Schwab U.S. Dividend Equity ETF (SCHD) reaches an … Read More

How the FM Global Invest Risk-Reward Rating Identifies the Best ETFs for Long-Term Investors

At FM Global Invest, we believe that sound investment decisions require a structured and transparent framework. That’s why we … Read More

PepsiCo: A Globally Diversified Dividend Compounder to Combine Income, Growth, and Reduce Volatility

PepsiCo is one of the world’s most diversified consumer staples companies, offering a rare combination of reliable dividend income, … Read More

LVMH: A High-Quality Global Luxury Leader With Strong Fundamentals

LVMH is a global leader in luxury goods, headquartered in France, operating in over 80 countries with more than … Read More

Allianz: A High-Conviction Pick With an Attractive Risk-Reward Profile

We evaluate companies through the lens of our proprietary FM Global Invest Risk-Reward Rating, a structured framework designed to … Read More

How We Identify High-Quality Companies: Inside the FM Global Invest Risk-Reward Rating

At FM Global Invest, we take a disciplined, research-driven approach to long-term investing. At the heart of our methodology … Read More

Building A $75,000 Dividend Portfolio: Enhancing SCHD With June’s High-Yield Picks

In this article, I outline a strategic $75,000 dividend portfolio that blends income, dividend growth, and capital appreciation. The … Read More